GB2376948B - Design synthesis and use of affinity ligands - Google Patents
Design synthesis and use of affinity ligandsInfo
- Publication number
- GB2376948B GB2376948B GB0223228A GB0223228A GB2376948B GB 2376948 B GB2376948 B GB 2376948B GB 0223228 A GB0223228 A GB 0223228A GB 0223228 A GB0223228 A GB 0223228A GB 2376948 B GB2376948 B GB 2376948B
- Authority
- GB
- United Kingdom
- Prior art keywords
- affinity ligands
- design synthesis
- synthesis
- design
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0005469.2A GB0005469D0 (en) | 2000-03-08 | 2000-03-08 | A novel building block approach for designing affinity ligands for glycosylated haemoglobin HbA1c |
PCT/GB2001/001011 WO2001066567A2 (en) | 2000-03-08 | 2001-03-08 | Design, synthesis and use of affinity ligands |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0223228D0 GB0223228D0 (en) | 2002-11-13 |
GB2376948A GB2376948A (en) | 2002-12-31 |
GB2376948B true GB2376948B (en) | 2004-09-29 |
Family
ID=9887130
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0005469.2A Ceased GB0005469D0 (en) | 2000-03-08 | 2000-03-08 | A novel building block approach for designing affinity ligands for glycosylated haemoglobin HbA1c |
GB0223228A Expired - Fee Related GB2376948B (en) | 2000-03-08 | 2001-03-08 | Design synthesis and use of affinity ligands |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0005469.2A Ceased GB0005469D0 (en) | 2000-03-08 | 2000-03-08 | A novel building block approach for designing affinity ligands for glycosylated haemoglobin HbA1c |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001240783A1 (en) |
GB (2) | GB0005469D0 (en) |
WO (1) | WO2001066567A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7399645B2 (en) * | 2004-05-12 | 2008-07-15 | Applera Corporation | Constrained cis-diol-borate bioconjugation system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021015A2 (en) * | 1997-10-21 | 1999-04-29 | Cranfield University | Affinity ligands, their production and use |
-
2000
- 2000-03-08 GB GBGB0005469.2A patent/GB0005469D0/en not_active Ceased
-
2001
- 2001-03-08 GB GB0223228A patent/GB2376948B/en not_active Expired - Fee Related
- 2001-03-08 AU AU2001240783A patent/AU2001240783A1/en not_active Abandoned
- 2001-03-08 WO PCT/GB2001/001011 patent/WO2001066567A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021015A2 (en) * | 1997-10-21 | 1999-04-29 | Cranfield University | Affinity ligands, their production and use |
Non-Patent Citations (3)
Title |
---|
Biochemical Society Transactions, Vol 19(4), 1991, Lewis et al, "Rational methods for site-directed drug...", pgs 883-887 * |
Biosensors & Bioelectronics, Vol 13(7-8), 1998, Chen et al, "The synthesis and screeening of a...", pgs 779-785 * |
Trends in Biotechnology, Vol 13(3), 1995, Bevan et al, "Identifying small-molecule lead...", pgs 115-121 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001240783A1 (en) | 2001-09-17 |
GB2376948A (en) | 2002-12-31 |
GB0223228D0 (en) | 2002-11-13 |
GB0005469D0 (en) | 2000-04-26 |
WO2001066567A2 (en) | 2001-09-13 |
WO2001066567A3 (en) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL152116A0 (en) | Prion-binding ligands and methods of using same | |
IL154272A0 (en) | The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands | |
GB2383962B (en) | Catalytic composition and use therefor | |
IL178864A0 (en) | 3'-prodrugs of 2'-deoxy-??-l-nucleosides | |
AU7593001A (en) | Alpha-msh related compounds and methods of use | |
GB2365142B (en) | Jamin-type interferometers and components therefor | |
IL154000A0 (en) | Use of antibodies against specific mhc-peptide complexes | |
EP1345606A4 (en) | Texaphyrin coordination compounds and uses thereof | |
IL151589A0 (en) | New combination of a betablocker and a cholestrol-lowering agent | |
TW444674U (en) | Improved structure of ornament | |
PL354799A1 (en) | Complex containing ocif and polysaccharide | |
AU2002346507A8 (en) | Benzazepine derivatives and their use as 5-ht ligands | |
GB0010318D0 (en) | Improvements in catalytic reduction of NoÎ | |
GB0007530D0 (en) | Trityl-type compounds and their use | |
GB0021497D0 (en) | Compounds and their use | |
GB2376948B (en) | Design synthesis and use of affinity ligands | |
AU8975701A (en) | Novel composition and use | |
AU2132002A (en) | Synthesis of small particles | |
GB0018758D0 (en) | Novel use and compunds | |
IL161608A0 (en) | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines | |
EP1392460A4 (en) | Hydrogenfluorides of aminosilanols and their use | |
HK1054306A1 (en) | Application of cosmetics | |
AU2001255708A1 (en) | Synthesis and use of thienotriazolodiazepines | |
AU5104101A (en) | Composition and use | |
GB0101462D0 (en) | Ligands and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20090308 |